Avanos Medical, Inc. (AVNS) Stock Score, Valuation & Financial Research
Avanos Medical, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 24/100.
Quick answer for AVNS
Avanos Medical, Inc. currently has a Wall Street Score of 24/100. The stored market price is $24.99. Its financial score is 35/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Avanos Medical, Inc. does
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression ther
AVNS financial snapshot
- Wall Street Score:
- 24/100
- Current price:
- $24.99
- Market capitalization:
- $1.17B
- Revenue:
- $715.9M
- Net income:
- $-69.4M
- Free cash flow:
- $43.1M
- Cash:
- $65.6M
- Total debt:
- $138.4M
- EPS:
- -1.50
- Financial score:
- 35/100
- Valuation score:
- 0/100
- Revenue score:
- 10/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $43.1M, showing positive cash generation.
- The balance sheet shows $65.6M of cash versus $138.4M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 35/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research AVNS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.